Product NDC: | 10544-105 |
Proprietary Name: | Hydrochlorothiazide |
Non Proprietary Name: | Hydrochlorothiazide |
Active Ingredient(s): | 25 mg/1 & nbsp; Hydrochlorothiazide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10544-105 |
Labeler Name: | Blenheim Pharmacal, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040412 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130328 |
Package NDC: | 10544-105-30 |
Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (10544-105-30) |
NDC Code | 10544-105-30 |
Proprietary Name | Hydrochlorothiazide |
Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (10544-105-30) |
Product NDC | 10544-105 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydrochlorothiazide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20130328 |
Marketing Category Name | ANDA |
Labeler Name | Blenheim Pharmacal, Inc. |
Substance Name | HYDROCHLOROTHIAZIDE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |